Navigation
Search
|
The first-ever patient in a Phase 3 medical study of LSD has successfully tripped balls
Monday December 16, 2024. 10:01 PM , from BoingBoing
Biopharma firm Mind Medicine announced that they have dosed the first-ever patient in a Phase 3 clinical trial of LSD. The individual tripped on lysergide D-tartrate, an LSD formulation for which the US FDA granted 'breakthrough therapy' status in March as a promising treatment for generalized anxiety disorder (GAD). — Read the rest The post The first-ever patient in a Phase 3 medical study of LSD has successfully tripped balls appeared first on Boing Boing.
https://boingboing.net/2024/12/16/the-first-ever-patient-in-a-phase-3-medical-study-of-lsd-has-succe...
Related News |
25 sources
Current Date
Dec, Wed 18 - 18:21 CET
|